{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T20:16:26Z","timestamp":1781727386096,"version":"3.54.5"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["390874280"],"award-info":[{"award-number":["390874280"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["158989968"],"award-info":[{"award-number":["158989968"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Virology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.coviro.2023.101316","type":"journal-article","created":{"date-parts":[[2023,3,29]],"date-time":"2023-03-29T18:11:18Z","timestamp":1680113478000},"page":"101316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Structural insights into hepatitis\u00a0C virus neutralization"],"prefix":"10.1016","volume":"60","author":[{"given":"Luisa J.","family":"Str\u00f6h","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4548-7241","authenticated-orcid":false,"given":"Thomas","family":"Krey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coviro.2023.101316_bib1","unstructured":"World Health Organization. Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021. Available at: https:\/\/www.who.int\/publications\/i\/item\/9789240027077external icon."},{"key":"10.1016\/j.coviro.2023.101316_bib2","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1146\/annurev-med-052915-015720","article-title":"Oral combination therapies for hepatitis C virus infection: successes, challenges, and unmet needs","volume":"68","author":"Naggie","year":"2017","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.coviro.2023.101316_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12954-019-0338-y","article-title":"High prevalence of hepatitis C virus infection and low level of awareness among people who recently started injecting drugs in a cross-sectional study in Germany, 2011-2014: missed opportunities for hepatitis C testing","volume":"17","author":"Enkelmann","year":"2020","journal-title":"Harm Reduct J"},{"key":"10.1016\/j.coviro.2023.101316_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jhep.2019.06.025","article-title":"Elimination of hepatitis C virus has limited impact on the functional and mitochondrial impairment of HCV-specific CD8+ T cell responses","volume":"71","author":"Aregay","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.coviro.2023.101316_bib5","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/cid\/civ948","article-title":"Risk of late relapse or reinfection with hepatitis C virus after achieving a sustained virological response: a systematic review and meta-analysis","volume":"62","author":"Simmons","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.coviro.2023.101316_bib6","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20010049","article-title":"Molecular mechanisms involved in HCC recurrence after direct-acting antiviral therapy","volume":"20","author":"Villani","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coviro.2023.101316_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2147\/JHC.S206668","article-title":"Hepatitis C antiviral therapy in patients with successfully treated hepatocellular carcinoma: dancing with wolves","volume":"6","author":"El Kassas","year":"2019","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.coviro.2023.101316_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.antiviral.2014.02.013","article-title":"The past, present and future of neutralizing antibodies for hepatitis C virus","volume":"105","author":"Ball","year":"2014","journal-title":"Antivir Res"},{"key":"10.1016\/j.coviro.2023.101316_bib9","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.3390\/ijms21165644","article-title":"Adaptive immune response against hepatitis C virus","volume":"21","author":"Kemming","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coviro.2023.101316_bib10","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJMoa2023345","article-title":"Randomized trial of a vaccine regimen to prevent chronic HCV infection","volume":"384","author":"Page","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coviro.2023.101316_bib11","doi-asserted-by":"crossref","first-page":"6367","DOI":"10.1016\/j.vaccine.2010.06.084","article-title":"Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults","volume":"28","author":"Frey","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.coviro.2023.101316_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059776","article-title":"A hepatitis C virus (HCV) vaccine comprising envelope glycoproteins gpE1\/gpE2 derived from a single isolate elicits broad cross-genotype neutralizing antibodies in humans","volume":"8","author":"Law","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.coviro.2023.101316_bib13","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.3389\/fimmu.2018.01480","article-title":"Hepatitis C vaccines, antibodies, and T cells","volume":"9","author":"Shoukry","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2023.101316_bib14","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/nm1698","article-title":"Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge","volume":"14","author":"Law","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/j.coviro.2023.101316_bib15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1093\/infdis\/jir511","article-title":"Vaccine-induced cross-genotype reactive neutralizing antibodies against hepatitis C virus","volume":"204","author":"Meunier","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.coviro.2023.101316_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007772","article-title":"Broadly neutralizing antibodies from an individual that naturally cleared multiple hepatitis C virus infections uncover molecular determinants for E2 targeting and vaccine design","volume":"15","author":"Keck","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.coviro.2023.101316_bib17","doi-asserted-by":"crossref","first-page":"10333","DOI":"10.1128\/JVI.00991-15","article-title":"Hepatitis C virus envelope glycoprotein E1 forms trimers at the surface of the virion","volume":"89","author":"Falson","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib18","doi-asserted-by":"crossref","first-page":"5017","DOI":"10.1093\/emboj\/cdf529","article-title":"The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus","volume":"21","author":"Scarselli","year":"2002","journal-title":"EMBO J"},{"key":"10.1016\/j.coviro.2023.101316_bib19","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1126\/science.282.5390.938","article-title":"Binding of hepatitis C virus to CD81","volume":"282","author":"Pileri","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.coviro.2023.101316_sbref19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41586-021-03913-5","article-title":"Structural insights into hepatitis C virus receptor binding and entry","volume":"598","author":"Kumar","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101316_bib21","doi-asserted-by":"crossref","first-page":"8012","DOI":"10.1128\/JVI.00038-09","article-title":"The tight junction-associated protein occludin is required for a postbinding step in hepatitis C virus entry and infection","volume":"83","author":"Benedicto","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib22","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1038\/nature07684","article-title":"Human occludin is a hepatitis C virus entry factor required for infection of mouse cells","volume":"457","author":"Ploss","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101316_bib23","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1053\/j.gastro.2009.02.080","article-title":"Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus","volume":"136","author":"Dowd","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.coviro.2023.101316_bib24","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.1128\/JVI.02458-15","article-title":"Antibody response to hypervariable region 1 interferes with broadly neutralizing antibodies to hepatitis C virus","volume":"90","author":"Keck","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib25","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/hep.28705","article-title":"Hypervariable region 1 shielding of hepatitis C virus is a main contributor to genotypic differences in neutralization sensitivity","volume":"64","author":"Prentoe","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.coviro.2023.101316_bib26","doi-asserted-by":"crossref","first-page":"5751","DOI":"10.1128\/JVI.02200-09","article-title":"Hepatitis C virus hypervariable region 1 modulates receptor interactions, conceals the CD81 binding site, and protects conserved neutralizing epitopes","volume":"84","author":"Bankwitz","year":"2010","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01909-18","article-title":"Hepatitis C virus escape studies of human antibody AR3A reveal a high barrier to resistance and novel insights on viral antibody evasion mechanisms","volume":"93","author":"Velazquez-Moctezuma","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib28","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1128\/JVI.01872-07","article-title":"Isolation and characterization of broadly neutralizing human monoclonal antibodies to the e1 glycoprotein of hepatitis C virus","volume":"82","author":"Meunier","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib29","doi-asserted-by":"crossref","first-page":"6205","DOI":"10.1073\/pnas.1114927109","article-title":"Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus","volume":"109","author":"Giang","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101316_bib30","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.3389\/fimmu.2018.01411","article-title":"Role of hepatitis C virus envelope glycoprotein E1 in virus entry and assembly","volume":"9","author":"Tong","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.coviro.2023.101316_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.689006","article-title":"Identification and characteristics of fusion peptides derived from enveloped viruses","volume":"9","author":"Lozada","year":"2021","journal-title":"Front Chem"},{"key":"10.1016\/j.coviro.2023.101316_bib32","doi-asserted-by":"crossref","DOI":"10.1186\/1423-0127-16-89","article-title":"Mutagenesis of the fusion peptide-like domain of hepatitis C virus E1 glycoprotein: involvement in cell fusion and virus entry","volume":"16","author":"Li","year":"2009","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.coviro.2023.101316_sbref32","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1126\/science.1243876","article-title":"Hepatitis C virus E2 envelope glycoprotein core structure","volume":"342","author":"Kong","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.coviro.2023.101316_bib34","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.chom.2018.10.009","article-title":"HCV broadly neutralizing antibodies use a CDRH3 disulfide motif to recognize an E2 glycoprotein site that can be targeted for vaccine design","volume":"24","author":"Flyak","year":"2018","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.coviro.2023.101316_bib35","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aav1882","article-title":"Genetic and structural insights into broad neutralization of hepatitis C virus by human VH1-69 antibodies","volume":"5","author":"Tzarum","year":"2019","journal-title":"Sci Adv"},{"key":"10.1016\/j.coviro.2023.101316_bib36","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abb5642","article-title":"An alternate conformation of HCV E2 neutralizing face as an additional vaccine target","volume":"6","author":"Tzarum","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.coviro.2023.101316_bib37","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.53169","article-title":"An ultralong CDRH2 in HCV neutralizing antibody demonstrates structural plasticity of antibodies against E2 glycoprotein","volume":"9","author":"Flyak","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.coviro.2023.101316_bib38","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz6225","article-title":"Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines","volume":"6","author":"He","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/j.coviro.2023.101316_bib39","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.immuni.2021.12.003","article-title":"Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization","volume":"55","author":"Weber","year":"2022","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2023.101316_bib40","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/nature13117","article-title":"Structure of the core ectodomain of the hepatitis C virus envelope glycoprotein 2","volume":"509","author":"Khan","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.coviro.2023.101316_bib41","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.immuni.2021.02.013","article-title":"Functional convergence of a germline-encoded neutralizing antibody response in rhesus macaques immunized with HCV envelope glycoproteins","volume":"54","author":"Chen","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.coviro.2023.101316_bib42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.coviro.2021.05.002","article-title":"Structural perspectives on HCV humoral immune evasion mechanisms","volume":"49","author":"Sevvana","year":"2021","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib43","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fmicb.2014.00329","article-title":"Challenges to the development of vaccines to hepatitis C virus that elicit neutralizing antibodies","volume":"5","author":"Drummer","year":"2014","journal-title":"Front Microbiol"},{"key":"10.1016\/j.coviro.2023.101316_bib44","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02070-18","article-title":"Broadly neutralizing antibodies targeting new sites of vulnerability in hepatitis C virus E1E2","volume":"93","author":"Colbert","year":"2019","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib45","doi-asserted-by":"crossref","first-page":"13085","DOI":"10.1128\/JVI.01939-12","article-title":"Structure of hepatitis C virus envelope glycoprotein E2 antigenic site 412 to 423 in complex with antibody AP33","volume":"86","author":"Kong","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib46","doi-asserted-by":"crossref","first-page":"9499","DOI":"10.1073\/pnas.1202924109","article-title":"Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1","volume":"109","author":"Kong","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101316_bib47","doi-asserted-by":"crossref","first-page":"2170","DOI":"10.1128\/JVI.02190-14","article-title":"Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies","volume":"89","author":"Meola","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib48","doi-asserted-by":"crossref","first-page":"10117","DOI":"10.1074\/jbc.M115.643528","article-title":"Structural basis for penetration of the glycan shield of hepatitis C virus E2 glycoprotein by a broadly neutralizing human antibody","volume":"290","author":"Li","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2023.101316_bib49","doi-asserted-by":"crossref","first-page":"12768","DOI":"10.1073\/pnas.1609780113","article-title":"Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen","volume":"113","author":"Kong","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.coviro.2023.101316_bib50","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02066-17","article-title":"Escape of hepatitis C virus from epitope I neutralization increases sensitivity of other neutralization epitopes","volume":"92","author":"Gu","year":"2018","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib51","doi-asserted-by":"crossref","first-page":"12923","DOI":"10.1128\/JVI.02052-12","article-title":"Toward a hepatitis C virus vaccine: the structural basis of hepatitis C virus neutralization by AP33, a broadly neutralizing antibody","volume":"86","author":"Potter","year":"2012","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00382-17","article-title":"Conformational flexibility in the immunoglobulin-like domain of the hepatitis C virus glycoprotein E2","volume":"8","author":"Vasiliauskaite","year":"2017","journal-title":"MBio"},{"key":"10.1016\/j.coviro.2023.101316_bib53","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.tim.2020.03.007","article-title":"The conformational states of the HIV-1 envelope glycoproteins","volume":"28","author":"Wang","year":"2020","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.coviro.2023.101316_bib54","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/10409230802058320","article-title":"Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme","volume":"43","author":"White","year":"2008","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"10.1016\/j.coviro.2023.101316_bib55","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-virology-092917-043300","article-title":"The many faces of a dynamic virion: implications of viral breathing on flavivirus biology and immunogenicity","volume":"5","author":"Dowd","year":"2018","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib56","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.virol.2011.10.023","article-title":"Hepatitis C virus epitope exposure and neutralization by antibodies is affected by time and temperature","volume":"422","author":"Sabo","year":"2012","journal-title":"Virology"},{"key":"10.1016\/j.coviro.2023.101316_bib57","doi-asserted-by":"crossref","first-page":"7456","DOI":"10.1128\/JVI.00685-16","article-title":"Role of conserved E2 residue W420 in receptor binding and hepatitis C virus infection","volume":"90","author":"Cowton","year":"2016","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib58","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.1128\/JVI.00271-06","article-title":"Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding","volume":"80","author":"Owsianka","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib59","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1128\/JVI.80.4.1734-1741.2006","article-title":"Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry","volume":"80","author":"Tscherne","year":"2006","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib60","doi-asserted-by":"crossref","first-page":"30361","DOI":"10.1074\/jbc.M111.263350","article-title":"Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion","volume":"286","author":"Sharma","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coviro.2023.101316_bib61","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1099\/vir.0.82567-0","article-title":"Mutagenesis of a conserved fusion peptide-like motif and membrane-proximal heptad-repeat region of hepatitis C virus glycoprotein E1","volume":"88","author":"Drummer","year":"2007","journal-title":"J Gen Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib62","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1128\/JVI.02642-06","article-title":"Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus","volume":"81","author":"Lavillette","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110859","article-title":"Sites of vulnerability in HCV E1E2 identified by comprehensive functional screening","volume":"39","author":"Pfaff-Kilgore","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/j.coviro.2023.101316_bib64","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-virology-031413-085521","article-title":"Mechanisms of virus membrane fusion proteins","volume":"1","author":"Kielian","year":"2014","journal-title":"Annu Rev Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib65","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/BJ20110868","article-title":"Distinct roles in folding, CD81 receptor binding and viral entry for conserved histidine residues of hepatitis C virus glycoprotein E1 and E2","volume":"443","author":"Boo","year":"2012","journal-title":"Biochem J"},{"key":"10.1016\/j.coviro.2023.101316_bib66","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nsmb.1456","article-title":"Viral membrane fusion","volume":"15","author":"Harrison","year":"2008","journal-title":"Nat Struct Mol Biol"},{"key":"10.1016\/j.coviro.2023.101316_sbref66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1126\/science.abn9884","article-title":"Structure of the hepatitis C virus E1E2 glycoprotein complex","volume":"378","author":"Torrents de la Pena","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.coviro.2023.101316_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/v13061027","article-title":"Structural and biophysical characterization of the HCV E1E2 heterodimer for vaccine development","volume":"13","author":"Toth","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.coviro.2023.101316_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186781","article-title":"HCV glycoprotein structure and implications for B-cell vaccine development","volume":"21","author":"Stroh","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.coviro.2023.101316_bib70","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.jmb.2015.06.012","article-title":"Structure of hepatitis C virus envelope glycoprotein E1 antigenic site 314-324 in complex with antibody IGH526","volume":"427","author":"Kong","year":"2015","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coviro.2023.101316_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5874","article-title":"Unexpected structure for the N-terminal domain of hepatitis C virus envelope glycoprotein E1","volume":"5","author":"El Omari","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2023.101316_bib72","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1128\/JVI.79.13.8400-8409.2005","article-title":"Role of N-linked glycans in the functions of hepatitis C virus envelope glycoproteins","volume":"79","author":"Goffard","year":"2005","journal-title":"J Virol"},{"key":"10.1016\/j.coviro.2023.101316_bib73","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cell.2016.09.056","article-title":"Crystal structure of a full-length human tetraspanin reveals a cholesterol-binding pocket","volume":"167","author":"Zimmerman","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.coviro.2023.101316_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4912","article-title":"The full-length cell-cell fusogen EFF-1 is monomeric and upright on the membrane","volume":"5","author":"Zeev-Ben-Mordehai","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.coviro.2023.101316_bib75","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a036830","article-title":"Hepatitis C virus entry: protein interactions and fusion determinants governing productive hepatocyte invasion","volume":"10","author":"Gerold","year":"2020","journal-title":"Cold Spring Harb Perspect Med"}],"container-title":["Current Opinion in Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625723000160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879625723000160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T08:04:39Z","timestamp":1778832279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879625723000160"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":75,"alternative-id":["S1879625723000160"],"URL":"https:\/\/doi.org\/10.1016\/j.coviro.2023.101316","relation":{},"ISSN":["1879-6257"],"issn-type":[{"value":"1879-6257","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural insights into hepatitis\u00a0C virus neutralization","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coviro.2023.101316","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101316"}}